Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
Clinical trial NCT04363164 · RECRUITING
Trial details
- NCT number
- NCT04363164
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2027-07-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.